Chronic vascular disease Circulatory System Varicose veins of other specified sites
Conditions
Interventions
Total of 84 patients - 28 patients randomised to each of the EndoVenous LAser therapy (EVLA) and RadioFrequency Ablation (RFA) groups, and 28 recruited to the surgery group).
Patients attend clinic
this will be approximately four weeks following initial consultation allowing sufficient time for the research participant to consider all available options. Following valid consent the procedure will
Sponsors
Wirral University Teaching Hospital (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects will be selected from those already undertaking an elective procedure for varicose veins 2. Patients aged 18 to 80 years old 3. Participants must be sufficiently mobile following procedure and have the availability to attend follow up 4. Patients must give informed consent to participate
Exclusion criteria
Exclusion criteria: 1. Patients who are pregnant or breast feeding 2. Patients with evidence of thrombus within the great saphenous vein
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess post operative pain, measured using the Visual Analogue Scale (VAS) score (0 = no pain, 10 = unbearable pain), following treatment of the great saphenous vein varicosities to evaluate efficacy of the treatments for varicose veins. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Evaluate the three different treatments: surgery, radiofrequency ablation and laser treatment 2. Assessment of post procedure bruising: presence and extent 3. Patient quality of life will be assessed by means of a questionnaire 4. Post procedure VCSS will also be calculated | — |
Countries
United Kingdom
Outcome results
None listed